What does WellTheory do?
WellTheory offers a comprehensive virtual care platform that focuses on whole-person care for autoimmune diseases. The platform is built on a research-backed program and utilizes an interdisciplinary team of experts, including registered dietitians and health coaches, to address the root cause of autoimmunity rather than merely masking symptoms.
How much did they raise?
The company raised $5M in new funding in a round led by Samsung Next, Opal Ventures, and Up2 Fund, with participation from existing investors Accel, OVO Fund, and BoxGroup. The fundraising details indicate strong support from both new and returning investors.
What are their plans for the money?
With the new funds, WellTheory plans to accelerate its expansion into the employer and health plan markets while further developing its AI-powered care infrastructure. This investment is expected to enhance the efficiency of its proprietary tools, such as Care Scribe and the Care Hub, ultimately improving patient care and operational capabilities.
What have they achieved so far?
WellTheory has already made significant progress with the implementation of Care Scribe, an AI assistant that has reduced provider prep and documentation time by 65%. This achievement demonstrates the effectiveness of their technology and sets a strong foundation for future growth.
